180
Participants
Start Date
January 11, 2017
Primary Completion Date
May 25, 2018
Study Completion Date
May 25, 2018
ALX-0171 3.0 mg/kg
ALX-0171 6.0 mg/kg
ALX-0171 9.0 mg/kg
Placebo
Investigator site 2, Brussels
Investigator site, Brussels
Investigator Site, Edegem
Investigator Site, Leuven
Investigator site, Roeselare
Investigator Site, Kozloduy
Investigator Site, Plovdiv
Investigator Site, Rousse
Investigator Site, Sofia
Investigator Site, Stara Zagora
Investigator Site, Santiago
Investigator site, Valdivia
Investigator Site, Floridablanca
Investigator Site 1, Medellín
Investigator site 2, Medellín
Investigator site, Santiago de Cali
Investigator site, Čakovec
Investigator site, Osijek
Investigator site, Slavonski Brod
Investigator site, Varaždin
Investigator site 1, Zagreb
Investigator site 2, Zagreb
Investigator site 3, Zagreb
Investigator site 4, Zagreb
Investigator site, Hradec Králové
Investigator Site, Tartu
Investigator site, Bochum
Investigator site, Dresden
Investigator Site, Sankt Augustin
Investigator Site, Wuppertal
Investigator Site, Balassagyarmat
Investigator site 1, Budapest
Investigator Site 2, Budapest
Investigator Site 3, Budapest
Investigator Site 4, Budapest
Investigator site, Debrecen
Investigator Site, Szeged
Investigator site, Székesfehérvár
Investigator Site, Veszprém
Investigator site, Beersheba
Investigator site, Haifa
Investigator site, Petah Tikva
Investigator Site, Daugavpils
Investigator Site, Riga
Investigator site, George Town
Investigator Site, Kuala Lumpur
Investigator Site, Seremban
Investigator Site, Sibu
Investigator Site, Alabang
Investigator site, Manila
Investigator Site 1, Quezon City
Investigator Site 2, Quezon City
Investigator site, Lublin
Investigator site, Trzebnica
Investigator site, Banská Bystrica
Investigator site, Bratislava
Investigator site, Košice
Investigator Site, Poprad
Investigator Site 1, Barcelona
Investigator Site 2, Barcelona
Investigator Site 3, Barcelona
Investigator Site, Bilbao
Investigator Site, El Palmar
Investigator site 1, Madrid
Investigator Site 2, Madrid
Investigator Site, Málaga
Investigator site, Santiago de Compostela
Investigator site, Seville
Investigator Site, Valencia
Investigator Site 1, Bangkok
Investigator site 2, Bangkok
Investigator Site, Chiang Mai
Investigator site, Hat Yai
Investigator Site, Khon Kaen
Ablynx, a Sanofi company
INDUSTRY